title: Orthotic management of the knee in patients with hemophilia.
abstract: The knee joint is the most frequently affected articulation in patients suffering from hemophilia. Before the availability of active coagulation factors, orthotic use was aimed at corrective functions. Orthotics in the modern era play a protective and preventative role, and they are used in the treatment of hemarthroses and in joints affected by chronic synovitis. Because levels of availability of clotting factors and orthotic material vary extensively world-wide, an overview is provided whereby each group of therapists can adapt themselves to the principles.
authors.affiliation: Israel National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Heim
authors.forename: U
authors.initials: U
authors.lastname: Martinowitz
authors.forename: H
authors.initials: H
authors.lastname: Horoszowski
mesh_terms: D000208:Acute Disease; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002908:Chronic Disease; D006395:Hemarthrosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006467:Hemophilia A / Q000150:complications*; D006801:Humans; D016916:Joint Deformities, Acquired / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D007592:Joint Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D007719:Knee Joint; D009989:Orthotic Devices; D010347:Patient Care Planning; D012008:Recurrence; D013585:Synovitis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy
chemical_list: D001779:Blood Coagulation Factors